UOB - Resilient operating earnings justifies premium

Tuesday, July 21, 2009

UOB outshines against its peers in terms of cost efficiency, earnings stability and high ROE. In 1Q09, it achieved the largest qoq cost savings and most stable net interest income (-0.8% vs peers’ -5%). Besides growing at 16% yoy in 1Q09 against the financial meltdown, UOB has been achieving better earnings stability in past years, recording 15-year core earnings CAGR of 11.6%, above the average of 10.5% for its peers.

Since the improvement in fair value of its AFS portfolio in 1Q09, UOB’s book value has reversed upwards from $8.90 to $9.37. Having the highest equity composition in its AFS investment portfolio (~10%) compared to its peers, UOB will be the prime beneficiary of the sharp rebound in equity values. The increase in equity prices globally (e.g. the MSCI world equity index was +19% since Apr and +39% since the low in March) points to further marked-to-market upside for UOB’s book value.

UOB’s well-managed asset quality is evident in the slight 6% qoq increase in its non-performing assets relative to a >20% jump at peers level in 1Q09. While specific provisions eased in 1Q09, the group has doubled up on its general provisions to buffer against the downturn. With coverage of 105% on its non-performing assets and a CAR ratio of 17.3% (highest in Singapore) that way exceeds regulatory requirement, UOB will be in good shape to emerge the crisis as a stronger player.

There are great opportunities for the group to expand its market share in the local SME segment where it has already carved a niche. SME lending in Singapore will stay buoyant backed by the government’s initiatives to undertake majority of the lending risks up to 80%. The government-backed loans in May have surged more than 400% from Jan. Besides, the recent resurgence in demand on private residential properties bodes well for UOB, which focuses on the private residential segment.

UOB’s share price underperformance (year-to-date) presents a good buying opportunity. Our target price is revised up to $17.10 pegged to 1.6x FY10 PBV (1.47x FY09 PBV previously) in line with its recovery PBV cycle. We are upgrading UOB to BUY.


Click here for more Banks and Financial Institutes Technical Analysis


Sponsored Links



Related Posts by Categories



Comments

No response to “UOB - Resilient operating earnings justifies premium”
Post a Comment | Post Comments (Atom)

Post a Comment

Disclaimers

These articles are neither an offer nor the solicitation of an offer to sell or purchase any investment. Its contents are based on information obtained from sources believed to be reliable and we make no representation and accepts no responsibility or liability as to its completeness or accuracy. We share them here as they are very informative, we claim no rights to these articles. If you own these articles, and do not wish to share it here, please do inform us by putting a comment and we will remove them immediately. We do not have any intentions to infringe any copyrights of yours. This is a place to keep record on the analyst recommendation for our own future references. We hope this serves as a record in the future, also make them searchable. We bear no responsibility for any profit, loss generated from these reports.
 
Citrus Pink Blogger Theme Design By LawnyDesignz Powered by Blogger